Adam G. Goodwill Northeast Ohio Medical University,
USA

11:30-11:45, 17 September (GMT AM 02:30-02:45)

 Satellite Symposium I - Pv Loop, Hemodynamic

Importance of Pressure-Volume (PV) Loops

1

Andrew J. Stewart Coats Monash University, Australia
& Univ. of Warwick, UK

16:45-17:00, 16 September (GMT AM 07:45-08:00)

 [Joint Session with HFA]
Upcoming ESC HF Guidelines, What's New?

What’s New in HFrEF?

09:50-10:20, 17 September (GMT AM 12:50-01:20)

 [Plenary Session] HFpEF

New HFpEF Diagnosis Concept. Is the Classification based on Ejection Fraction Kept on?

Anna Stromberg Linkoping University,
Sweden

17:45-18:00, 18 September (GMT AM 08:45-09:00)

Comprehensive HF Care

Intervention to Address Frailty in HF

Barry Greenberg USCD, JACC:HF, USA

15:00-15:20, 16 September (GMT AM 06:00-06:20)

[IJHF Editorial Session]
Jump Up to the Global Platform

How to Get My Paper Accepter in JACC:HF

Biykem Bozkurt Baylor College of Medicine,
USA

13:50-14:10, 18 September (GMT AM 04:50-05:10)

 [Joint Session with HFSA]
Quadruple Therapy for HFrEF Patient

Challenge of Prescribing Inertia: from CHAMP-HF Registry

Christopher S. Hayward St. Vincent's Hospital,
Australia

11:45-12:00, 18 September (GMT AM 02:45-03:00)

 Satellite Symposium VI - VAD/TPL

Allograft Dysfunction: A Clinician's Approach to a Common Dilemma

Gerasimos Filippatos National & Kapodistrian University
of Athens, Greece

17:00-17:15, 16 September (GMT AM 08:00-08:15)

 [Joint Session with HFA]
Upcoming ESC HF Guidelines, What's New?

What’s New in HFpEF?

Giuseppe Rosano St George’s University Medical
School of London, UK

09:00-09:20, 17 September (GMT AM 12:00-12:20)

 [Young HF Specialist Education Session]
Educational Programs for Specialist

Introduction of ESC (or HFA) Educational Program

Hiroyuki Tsutsui Kyushu University,
Japan

14:30-14:45, 17 September (GMT AM 05:30-05:45)

 [Joint Session with JHFS]
HF Management - New Perspectives

Recent Clinical Trials of Pharmacologic Therapy for Heart Failure

Howard J. Eisen Pennsylvania State University,
USA

16:00-16:15, 18 September (GMT AM 07:00-07:15)

 [Joint Session with ISHLT]
Challenges in Heart Transplantation & MCS

Future Perspective in MCS

James Januzzi Harvard University,
USA

09:50-10:20, 18 September (GMT AM 12:50-01:20)

 [Plenary Session] HFrEF

Optimal HFrEF Treatment, New Perspectives

Javid Moslehi Vanderbilt University,
USA

15:00-15:15, 16 September (GMT 06:00-06:15)

 [Joint Session with Cardio-oncology]
Cancer related Cardiac Failure

Immune Checkpoint Inhibitor-Associated Myocarditis: Learning from Mice and Humans

Jian Zhang Fuwai Hospital Chinese Academic
of Medical Science, China

17:30-17:45, 18 September (GMT AM 08:30-08:45)

 [Joint Session with CHFA]
Contemporary HF Etiology of Eastern Asian

Acute and Chronic Myocarditis

JoAnn Lindenfeld Vanderbilt University Medical Center,
USA

14:25-14:45, 18 September (GMT AM 05:25-05:45)

 [Joint Session with HFSA]
Quadruple Therapy for HFrEF Patient

Benefits of Quadruple Therapy for HFrEF

John McMurray University of Glasgow,
UK

16:15-16:30, 18 September (GMT AM 07:15-07:30)

 Role of Novel Pillar, SGLT2 Inhibitor

Positioning of SGLT2 Inhibitors in HF Management: How Should We Sequence?

Jon A Kobashigawa Cedars-Sinai Medical Center,
USA

14:00-14:15, 17 September (GMT AM 05:00-05:15)

 End Stage HF

Utilization of Marginal Donors in Heart Transplantation

Kazunori Shimada Juntendo University Hospital,
Japan

11:45-12:00, 18 September (GMT AM 02:45-03:00)

 Satellite Symposium V - Rehab

Skeletal Muscle and Prognosis of HF: Can Cardiac Rehabilitation Overcome Muscle Wasting?

Khung Keong Yeo National Heart Centre Singapore,
Singapore

15:45-16:00, 18 September (GMT AM 06:45-07:00)

 [Joint Session with KSIC - Structural Heart Disease]
Intervention Approach for Structural Etiology of HF

Percutaneous Edge-to-Edge Mitral Valve Repair for functional MR

Kiran Kaur Khush Stanford University,
USA

15:30-15:45, 18 September (GMT AM 06:30-06:45)

 [Joint Session with ISHLT]
Challenges in Heart Transplantation & MCS

The Heart Transplant Donor Shortage: Challenges to Overcome

Koichiro Kuwahara Shinshu University,
Japan

14:00-14:15, 17 September (GMT AM 05:00-05:15)

 [Joint Session with JHFS]
HF Management - New Perspectives

Transcriptional Circuits Underlying Heart Failure

Lars SØndergaard University of Copenhagen,
Denmark

15:30-15:45, 18 September (GMT AM 06:30-06:45)

 [Joint Session with KSIC - Structural Heart Disease]
Intervention Approach for Structural Etiology of HF

Transcatheter Treatment of Heart Failure Using a Novel Interatrial Implant to Lower Left Atrial Pressure

Mandeep R. Mehra Harvard Medical School,
USA

14:30-14:45, 17 September (GMT AM 05:30-05:45)

 End Stage HF

The Right Ventricle and LVAD Therapy

Michael Böhm Saarland University Hospital,
Homburg, Germany

10:20-10:50, 18 September (GMT AM 01:20-01:50)

 [Plenary Session] HFrEF

Role of SGLT2I from Chronic to Acute HF, Where Is Proper Position in GDMT?

Ray Hershberger Ohio State University,
USA

11:30-11:45, 18 September (GMT AM 02:30-02:45)

 Satellite Symposium IV - Gene

Update on the Genetic Evaluation of Dilated Cardiomyopathy

Stefan D. Anker Charite Campus Virchow Clinic,
Germany

10:20-10:50, 17 September (GMT AM 01:20-01:50)

 [Plenary Session] HFpEF

Pharmacological Treatment of HFpEF

Thibaud Damy Assistance Publique des Hôpitaux de
Paris, France

15:45-16:00, 16 September (GMT AM 06:45-07:00)

 [Joint Session with Cardio-oncology]
Cancer related Cardiac Failure

Multiple Myeloma and Cardiac Amyloidosis : Challenges of Management

Yuhui Zhang Fuwai Hospital Chinese Academic
of Medical Science, China

17:00-17:15, 18 September (GMT AM 08:00-08:15)

 [Joint Session with Cardio-oncology]
Cancer related Cardiac Failure

Ischemic Cardiomyopathy